Holme E R, Qi M, Ahmed A E, Veitch J, Auda G, Whaley K
Department of Pathology, University of Glasgow, Western Infirmary, U.K.
Mol Immunol. 1992 Jul-Aug;29(7-8):957-64. doi: 10.1016/0161-5890(92)90134-j.
RHP has been purified from the plasma of both normal individuals and patients with rheumatoid arthritis (RA). RHP from both these sources was shown to be identical with Factor H by reaction with antisera and N-terminal amino acid sequence analysis. Factor H, from both normal and RA sera, inhibited the solubilization of immune precipitates but did not affect prevention of immune precipitation. Factor H was shown to inhibit the haemolytic activity of fluid-phase C1, but unlike C1-inhibitor, it had little effect on C1 bound to EA (EAC1). Factor H was shown to complex with intact C1, to isolated C1q and to the C1r:C1s tetramer. However, binding of factor H to C1 did not dissociate the C1 macromolecule. A C1-Factor H complex was detected in the serum and plasma from normal individuals and patients with systemic lupus erythematosus and RA. Serum levels of this complex were reduced, by EDTA-treatment of serum and by activation of complement by the classical pathway.
RHP已从正常个体和类风湿性关节炎(RA)患者的血浆中纯化出来。通过与抗血清反应和N端氨基酸序列分析表明,来自这两种来源的RHP与H因子相同。来自正常和RA血清的H因子均能抑制免疫沉淀物的溶解,但不影响免疫沉淀的预防。已证明H因子能抑制液相C1的溶血活性,但与C1抑制剂不同的是,它对与EA(EAC1)结合的C1几乎没有影响。已证明H因子能与完整的C1、分离的C1q以及C1r:C1s四聚体形成复合物。然而,H因子与C1的结合并未使C1大分子解离。在正常个体以及系统性红斑狼疮和RA患者的血清和血浆中检测到了C1-H因子复合物。通过血清的EDTA处理和经典途径激活补体,该复合物的血清水平降低。